Aparna Organics Profile
Key Indicators
- Authorised Capital ₹ 34.00 Cr
as on 28-11-2024
- Paid Up Capital ₹ 16.85 Cr
as on 28-11-2024
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 90.57 Cr
as on 28-11-2024
- Revenue -56.57%
(FY 2023)
- Profit -120.44%
(FY 2023)
- Ebitda -235.67%
(FY 2023)
- Net Worth -479.48%
(FY 2023)
- Total Assets -14.49%
(FY 2023)
About Aparna Organics
- CIN/LLPIN
U24232TG2008PLC058745
- Company No.
058745
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2008
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aparna Organics Limited offer?
Aparna Organics Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Blood Pressure Medicine, Anticoagulant and Antiplatelet Drugs, Brain & Nervous System Drugs, Psychotherapeutic Agents, Pharma Ingredients & Raw Materials, Blood System and Cardiovascular API, API (Active Pharmaceutical Ingredients), Antidepressant & Anti Anxiety Medicines, Pregabalin Capsules.
Who are the key members and board of directors at Aparna Organics?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Chennuru  | Managing Director | 20-Mar-2021 | Current |
| Deepak Makhija | CFO | 20-Oct-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venu Bommireddy | Director | 15-Feb-2022 | Current |
| Kanumuri Raju | Director | 18-Feb-2022 | Current |
| Pochana Reddy | Director | 20-Mar-2021 | Current |
| Jeedigunta Kumar | Director | 15-Feb-2022 | Current |
Financial Performance and Corporate Structure Insights of Aparna Organics.
Aparna Organics Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 56.57% decrease. The company also saw a substantial fall in profitability, with a 120.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 479.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aparna Organics?
In 2023, Aparna Organics had a promoter holding of 94.07% and a public holding of 5.93%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Innroad Software Development Services Private LimitedActive 8 years 6 monthsRakesh Chennuru is a mutual person
Aparna Pharmaceuticals Private LimitedActive 4 years 3 monthsRakesh Chennuru, Pochana Reddy and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Feb 2019 | ₹1.12 Cr | Satisfied |
Others Creation Date: 31 Aug 2018 | ₹5.60 M | Satisfied |
Others Creation Date: 30 Jun 2018 | ₹1.13 Cr | Satisfied |
How Many Employees Work at Aparna Organics?
Unlock and access historical data on people associated with Aparna Organics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aparna Organics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aparna Organics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
